(Q43079484)

13 November 2017

title

Candidaemia associated with decreased in vitro fluconazole susceptibility: is Candida speciation predictive of the susceptibility pattern? (English)

1 reference

13 November 2017

1 reference

1 reference

1 reference

Dimitrios P Kontoyiannis

10

object named as

Dimitrios P Kontoyiannis

1 reference

13 November 2017

David A Oxman

1

1 reference

13 November 2017

Jennifer K Chow

2

1 reference

13 November 2017

Gyorgy Frendl

3

1 reference

13 November 2017

Susan Hadley

4

1 reference

13 November 2017

Shay Hershkovitz

5

1 reference

13 November 2017

Peter Ireland

6

1 reference

13 November 2017

Laura A McDermott

7

1 reference

13 November 2017

Katy Tsai

8

1 reference

13 November 2017

Francisco M Marty

9

1 reference

13 November 2017

Yoav Golan

11

1 reference

13 November 2017

language of work or name

English

0 references

publication date

29 April 2010

1 reference

Journal of Antimicrobial Chemotherapy

13 November 2017

number of pages

6

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

13 November 2017

volume

65

1 reference

13 November 2017

issue

7

1 reference

13 November 2017

page(s)

1460-1465

1 reference

Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America.

13 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ136

Effects of fluconazole administration in critically ill patients: analysis of bacterial and fungal resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ136

Emerging evidence of selection of fluconazole-tolerant fungi in surgical intensive care units

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ136

Decrease in Candida albicans strains with reduced susceptibility to fluconazole following changes in prescribing policies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ136

Candida krusei fungaemia: antifungal susceptibility and clinical presentation of an uncommon entity during 15 years in a single general hospital

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ136

Candida albicans versus non-albicans bloodstream infection in patients in a tertiary hospital: an analysis of microbiological data

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ136

In vitro susceptibilities of bloodstream isolates of Candida species to six antifungal agents: results from a population-based active surveillance programme, Barcelona, Spain, 2002-2003.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ136

Activity of voriconazole, itraconazole, fluconazole and amphotericin B in vitro against 1763 yeasts from 472 patients in the voriconazole phase III clinical studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ136

Therapy and outcome of Candida glabrata versus Candida albicans bloodstream infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ136

Delaying the empiric treatment of candida bloodstream infection until positive blood culture results are obtained: a potential risk factor for hospital mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ136

The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ136

Factors associated with candidemia caused by non-albicans Candida species versus Candida albicans in the intensive care unit

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ136

Risk factors for albicans and non-albicans candidemia in the intensive care unit

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ136

Candidemia in nonneutropenic critically ill patients: risk factors for non-albicans Candida spp.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ136

Risk factors for vancomycin-resistant Enterococcus (VRE) infection in colonized patients with cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ136

Risk factors for colonization with extended-spectrum beta-lactamase-producing bacteria and intensive care unit admission.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ136

Results from the ARTEMIS DISK Global Antifungal Surveillance study, 1997 to 2005: an 8.5-year analysis of susceptibilities of Candida species and other yeast species to fluconazole and voriconazole determined by CLSI standardized disk diffusion test

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ136

Use of peptide nucleic acid-fluorescence in situ hybridization for definitive, rapid identification of five common Candida species

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ136

Cost savings with implementation of PNA FISH testing for identification of Candida albicans in blood cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ136

21 January 2018

Identifiers

DOI

10.1093/JAC/DKQ136

1 reference

13 November 2017

1 reference